132 related articles for article (PubMed ID: 26531330)
1. Type III TGF-β receptor inhibits cell proliferation and migration in salivary glands adenoid cystic carcinoma by suppressing NF-κB signaling.
Xu D; Li D; Lu Z; Dong X; Wang X
Oncol Rep; 2016 Jan; 35(1):267-74. PubMed ID: 26531330
[TBL] [Abstract][Full Text] [Related]
2. The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2.
You HJ; How T; Blobe GC
Carcinogenesis; 2009 Aug; 30(8):1281-7. PubMed ID: 19325136
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of the type III TGF-β receptor enhances metastasis and invasion in hepatocellullar carcinoma progression.
Zhang S; Sun WY; Wu JJ; Gu YJ; Wei W
Oncol Rep; 2016 Apr; 35(4):2373-81. PubMed ID: 26882862
[TBL] [Abstract][Full Text] [Related]
4. Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin.
Sun ZJ; Chen G; Hu X; Zhang W; Liu Y; Zhu LX; Zhou Q; Zhao YF
Apoptosis; 2010 Jul; 15(7):850-63. PubMed ID: 20386985
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between proteoglycans and proliferation of human salivary adencid cystic carcinoma].
Shi H; Wang J; Dong FS; Wang X; Li HX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Jan; 45(1):20-5. PubMed ID: 20368035
[TBL] [Abstract][Full Text] [Related]
6. A20 inhibits human salivary adenoid cystic carcinoma cells invasion via blocking nuclear factor-kappaB activation.
Zhang B; Guan CC; Chen WT; Zhang P; Yan M; Shi JH; Qin CL; Yang Q
Chin Med J (Engl); 2007 Oct; 120(20):1830-5. PubMed ID: 18028781
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA155 in the growth and invasion of salivary adenoid cystic carcinoma.
Liu L; Hu Y; Fu J; Yang X; Zhang Z
J Oral Pathol Med; 2013 Feb; 42(2):140-7. PubMed ID: 22823535
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
[TBL] [Abstract][Full Text] [Related]
9. A tumor-promoting role for soluble TβRIII in glioblastoma.
Burghardt I; Schroeder JJ; Weiss T; Gramatzki D; Weller M
Mol Cell Biochem; 2021 Aug; 476(8):2963-2973. PubMed ID: 33772427
[TBL] [Abstract][Full Text] [Related]
10. [Expression of TGF beta 1 and TGF beta RI proteins in tissues of salivary adenoid cystic carcinoma].
Guo F; Jian XC; Cheng RX
Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):229-32. PubMed ID: 12575299
[TBL] [Abstract][Full Text] [Related]
11. Notch-1 knockdown suppresses proliferation, migration and metastasis of salivary adenoid cystic carcinoma cells.
Chen W; Cao G; Yuan X; Zhang X; Zhang Q; Zhu Y; Dong Z; Zhang S
J Transl Med; 2015 May; 13():167. PubMed ID: 25990317
[TBL] [Abstract][Full Text] [Related]
12. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC
Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987
[TBL] [Abstract][Full Text] [Related]
13. Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth.
Gatza CE; Holtzhausen A; Kirkbride KC; Morton A; Gatza ML; Datto MB; Blobe GC
Neoplasia; 2011 Aug; 13(8):758-70. PubMed ID: 21847367
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of type III TGF-β receptor aggravates lung fibrotic process.
Ahn JY; Park S; Yun YS; Song JY
Biomed Pharmacother; 2010 Sep; 64(7):472-6. PubMed ID: 20359848
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of transforming growth factor type III receptor restores TGF-β1 sensitivity in human tongue squamous cell carcinoma cells.
Li D; Xu D; Lu Z; Dong X; Wang X
Biosci Rep; 2015 Jul; 35(4):. PubMed ID: 26205654
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB promotes iNOS and VEGF expression in salivary gland adenoid cystic carcinoma cells and enhances endothelial cell motility in vitro.
Zhang J; Peng B
Cell Prolif; 2009 Apr; 42(2):150-61. PubMed ID: 19317804
[TBL] [Abstract][Full Text] [Related]
17. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
Gibbons MD; Manne U; Carroll WR; Peters GE; Weiss HL; Grizzle WE
Laryngoscope; 2001 Aug; 111(8):1373-8. PubMed ID: 11568571
[TBL] [Abstract][Full Text] [Related]
18. [The relation of nuclear factor kappa B to angiogenesis and clinical outcomes in adenoid cystic carcinoma of salivary glands].
Zhang JL; Peng B; Chen XM
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Nov; 40(6):495-9. PubMed ID: 16329838
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of the transforming growth factor-beta type III receptor impairs motility and invasion of metastatic cancer cells.
Criswell TL; Dumont N; Barnett JV; Arteaga CL
Cancer Res; 2008 Sep; 68(18):7304-12. PubMed ID: 18794117
[TBL] [Abstract][Full Text] [Related]
20. Aberrant Wnt-1/beta-catenin signaling and WIF-1 deficiency are important events which promote tumor cell invasion and metastasis in salivary gland adenoid cystic carcinoma.
Wang R; Geng N; Zhou Y; Zhang D; Li L; Li J; Ji N; Zhou M; Chen Y; Chen Q
Biomed Mater Eng; 2015; 26 Suppl 1():S2145-53. PubMed ID: 26405993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
